$4.59
-7.8%The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
Warren Buffett's Owner Earnings DCF analysis for intrinsic value calculation
Base year metrics used for projections
Forecast period and terminal assumptions
Calculation flow from present value to intrinsic value per share
Operating Cash Flow - Maintenance CapEx = Owner Earnings
| Metric | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | Year 6 | Year 7 | Year 8 | Year 9 | Year 10 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$26.6M | -$28.9M | -$31.3M | -$33.9M | -$36.8M | -$39.8M | -$43.2M | -$46.8M | -$50.7M | -$55.0M |
| Maintenance CapEx | -$693.6K | -$751.7K | -$814.7K | -$882.9K | -$956.8K | -$1.0M | -$1.1M | -$1.2M | -$1.3M | -$1.4M |
| Owner Earnings | -$27.3M | -$29.6M | -$32.1M | -$34.8M | -$37.7M | -$40.9M | -$44.3M | -$48.0M | -$52.0M | -$56.4M |
| Discount Factor | 0.926 | 0.857 | 0.794 | 0.735 | 0.681 | 0.630 | 0.583 | 0.540 | 0.500 | 0.463 |
| Present Value | -$25.3M | -$25.4M | -$25.5M | -$25.6M | -$25.7M | -$25.8M | -$25.8M | -$25.9M | -$26.0M | -$26.1M |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.